Aion Therapeutic Announces Director Resignation
TORONTO, July 6, 2023 /CNW/ - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announces that effective July 5, 2023, Rosy Mondin has resigned as a director of the Company. The Company thanks Mrs. Mondin for her service as a director of the Company and wishes her all the best in her future endeavors.
Aion Therapeutic is a forward-thinking business within the health and wellness sector with a diverse portfolio of intellectual property. With a commitment to innovation and transformative solutions, the Company is poised to drive positive change to redefine the boundaries of health and wellness.
The Canadian Securities Exchange (operated by CNSX Markets Inc.) has neither approved nor disapproved of the contents of this press release.
SOURCE AION THERAPEUTIC INC.
Aion Therapeutic Inc. Graham Simmonds Executive Vice Chair & CEO, (416) 843-2881
Share this article